About Natco Pharma
Natco Pharma is a company based in Hyderabad (India) founded in 1981 by Venkaiah Chowdary Nannapaneni. The company has 4,960 employees as of March 31, 2024. Natco Pharma has completed 1 acquisition, including Dash Pharmaceuticals. Natco Pharma offers products and services including Generic Drugs and Active Pharmaceutical Ingredients.
- Headquarter Hyderabad, India
- Employees 4960 as on 31 Mar, 2024
- Founders Venkaiah Chowdary Nannapaneni
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Natco Pharma Limited
-
Annual Revenue
$516.78 M (USD)10.88as on Mar 31, 2025
-
Net Profit
$220.64 M (USD)35.81as on Mar 31, 2025
-
EBITDA
$263.01 M (USD)23.45as on Mar 31, 2025
-
Latest Funding Round
$143.25 M (USD), Post-IPO
Dec 01, 2017
-
Investors
Multiples Alternate Asset Management
& 2 more
-
Employee Count
4960
as on Mar 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Natco Pharma
Natco Pharma is a publicly listed company on the NSE with ticker symbol NATCOPHARM in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Natco Pharma
Natco Pharma offers a comprehensive portfolio of products and services, including Generic Drugs and Active Pharmaceutical Ingredients.
Generic versions of oncology drugs are developed and marketed to enhance affordability in domestic and international markets
Active pharmaceutical ingredients are manufactured and supplied from specialized facilities to support formulation needs
People of Natco Pharma
Unlock access to complete
Unlock access to complete
Leadership Team
16 people
Sales and Marketing
6 people
Deputy Team
5 people
Product Management Team
4 people
Software Development Team
3 people
Legal and Compliance
3 people
Finance and Accounting
3 people
Human Resources and Administration
3 people
Unlock access to complete
Funding Insights of Natco Pharma
Investors in Natco Pharma
Natco Pharma has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Multiples Alternate Asset Management, CX Partners and Kotak Investment Advisors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment partnerships, entrepreneur support, and profit-focused services in finance.
|
Locked | Locked | Locked | |
|
Private equity investments in India are managed by CX Partners.
|
Locked | Locked | Locked | |
|
Provider of investment advisory services
|
Locked | Locked | Locked |
Investor details for Natco Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Natco Pharma
Natco Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Dash Pharmaceuticals.
Investment portfolio details for Natco Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Advanced spectroscopic and laser instrumentation is developed for industrial applications.
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for Natco Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Natco Pharma
Detailed financials for Natco Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Natco Pharma Comparisons
Peer comparison for Natco Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Natco Pharma
Detailed competitors of Natco Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Natco Pharma
Complete news archive for Natco Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Natco Pharma
Natco Pharma was founded in 1981 and raised its 1st funding round 30 years after it was founded.
Natco Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Rajeev Nannapaneni is the current CEO of Natco Pharma.
As of Mar 31, 2024, the latest employee count at Natco Pharma is 4,960.
Annual revenue of Natco Pharma is $516.78M as on Mar 31, 2025.
Natco Pharma was founded in 1981 and is headquartered in Hyderabad, India. Operations are focused on the pharmaceutical sector, where active pharmaceutical ingredients and finished dosage forms are developed and manufactured. A pipeline of generic drugs is maintained, alongside a drug discovery research program in oncology. Emphasis is placed on niche therapeutic areas, complex products, contract manufacturing, and marketing of drug formulation services.
Natco Pharma offers Generic Drugs and Active Pharmaceutical Ingredients.
Yes, Natco Pharma is publicly traded on NSE under the ticker symbol NATCOPHARM.
Natco Pharma has made 1 acquisition, including Dash Pharmaceuticals.
Natco Pharma has 3 investors. Key investors include Multiples Alternate Asset Management, CX Partners, and Kotak Investment Advisors.
The ticker symbol of Natco Pharma is NATCOPHARM on NSE.